UBS
-
A swift combination of the UK investment banking teams of UBS and Credit Suisse shows the rapid progress that has been made, as CEO Sergio Ermotti looks ahead to a ‘pivotal 2024’ -
Kiwi sub-sovereign sacrifices size to price tight
-
Flavour and fragrance company capitalises on investor demand to take size at a tight price
-
◆ Deal marketed at a price to sell ◆ Structure suggests UBS is optimising funding volume ◆ Reluctance to buy Swiss AT1s remains but fixed income markets are recovering
-
Higher rates are powering an equilibrium in the AT1 market that may tempt even the most unlikely of issuers to come to the market
-
Name recognition helps bank go against the grain to tighten pricing
-
Former IB co-CEO to join as vice-chair of corporate and investment bank
-
Strong name recognition helps Swiss pharma company achieve size at a tight price
-
Richard Bärlocher will take over the management of Swiss bond issuers from next year
-
No let-up in issuance but investors running short on cash
-
Bank overcame challenging market conditions to price its second Swiss deal of the year
-
South Korean policy bank aims to continue a bumper year of funding with Swiss bond
